

Scores at time of recommendation (January 4, 2026)
2026 Q2 (June/July 2026)
Strong quarterly results marked the period. The company reported net income available to common shareholders of $654.2M and operating income available to common shareholders of $547.8M. Tangible book value per share increased 27% year-over-year, with operating ROE reaching approximately 20% for the quarter. [3][14]
Investor perception shifted toward viewing RenRe as a resilient, high-return reinsurer delivering outsized ROE and tangible book value growth despite prior catastrophe volatility. The narrative evolved to frame the company as a compounder with strong capital returns. [3][14]
An uptrend developed as earnings beats and rising book value drove buying pressure into mid-2026. [3][14]
2026 Q1 (April 2026)
The company reported quarterly net income available to common shareholders of $284.5M and operating income available to common shareholders of $590.5M. Strong underwriting, fee and investment contributions remained disclosed. [1]
The narrative reinforced perception of diversified profit drivers across underwriting, fees and investments, with resilience demonstrated after earlier large-loss periods. Investors grew increasingly confident in management's capital allocation approach, including dividends and buybacks. [1][11]
A constructive uptrend continued following confirmation of sustained profitability early in the year. [1][11]
2025 Full Year
Record-like results emerged for the year. The company delivered net income available to common shareholders of approximately $2.6B and operating income available to common shareholders of approximately $1.9B. A 26% return on average common equity and 18% operating ROE were reported for 2025. The company executed approximately $1.6B in share repurchases and continued quarterly dividends of $0.40 per share. [9][4][2]
Market perception shifted to credit RenRe's integration and capital discipline, including Validus operational synergies and buybacks, for sharply improved returns. Investors framed the company as generating shareholder-friendly excess capital while navigating catastrophe exposures. [9][11][2]
A breakout and strong uptrend developed through 2025 as buybacks, improving returns and rising book value lifted the stock from earlier drawdown levels. [9][11]
2025 Q1 (Jan–Apr 2025)
Large catastrophe-driven underwriting pain emerged. The company reported more than $1.7B of net claims and claims expenses for the quarter, driven by nearly $1.6B net from January California wildfires, resulting in an underwriting loss. [7]
Short-term concern re-emerged regarding volatility of underwriting results and event risk. However, investors weighed these losses against the strong capital base and management's prior track record of returning capital. A temporary shift to a cautious tone occurred, though the longer-term improvement narrative remained intact. [7][11]
Short-term drawdown and volatility in price occurred during Q1 2025 around wildfire loss disclosures, with trading ranges widening as the market re-priced near-term earnings uncertainty. [7]
2024
The company continued operating within an active catastrophe environment. Improving operating metrics were reported, with growth highlighted in property segment profitability in investor materials. Management emphasized industry-wide elevated insured catastrophe losses, with FY24 disclosures used to set 2025 targets and capital return policy. [5][6]
Investors recognized RenRe's underwriting discipline and diversified revenue, including fee businesses, allowing it to deliver returns despite elevated industry catastrophe losses. The perception developed of disciplined value with upside from capital deployment. [5][6]
Price action remained range-bound to modestly upward as markets digested elevated loss activity but rewarded demonstrated profitability and capital returns. [5][6]
2023 Full Year
A meaningful rebound occurred from 2022. The company reported operating income available to common shareholders of $315.6M. Industry catastrophe losses exceeded $100B (cited at $120B), yet RenRe posted positive operating results. [8][6]
The narrative moved from recovery to stabilization. RenRe demonstrated it could earn operating profits in an active catastrophe year, restoring investor confidence after 2022 large-loss impacts and showing better underwriting resilience. [8][6]
A recovery rally developed as a transition out of prior drawdown occurred. A technical base formed through 2022 into 2023, then lifted on improving results. [8][6]
2022 Full Year
Heavy catastrophe impact defined the year. The company reported an annual net loss available to common shareholders driven by Hurricane Ian and other weather-related large losses. 2022 was a major loss year for both the industry and RenRe specifically. [8][6]
Investor perception turned cautious and negative. RenRe was viewed as materially hit by event risk and became a value/trouble candidate as underwriting losses pressured capital and return metrics. Calls for tighter underwriting and capital discipline increased. [8][6]
A major drawdown occurred through 2022 as markets re-priced the stock lower on the net loss and uncertainty, followed by a bottoming process into 2023. [8][6]
2021
The post-COVID market environment brought normalization of underwriting cycles. RenRe reported routine quarterly results and managed capital while preparing for subsequent catastrophe volatility in following years. [13]
The company was viewed as a large, diversified reinsurer with a competitive underwriting platform. Perception was neutral-to-constructive entering the active catastrophe years that followed. [13]
Relatively stable, range-bound price action characterized 2021 before increased volatility and drawdowns began in 2022. [13]
RenaissanceRe is a leading catastrophe reinsurer with exceptional operational discipline and structural competitive advantages. The company benefits from a business model in which customers are forced by regulation to reinsure and inflation and rising claims sums tend to lead to higher premiums. The strong capital base, coupled with intelligent capital allocation and an attractive valuation level, make the share an unusually solid player in an often volatile sector.
RenaissanceRe is a Bermuda-based specialty reinsurer operating across property catastrophe reinsurance, specialty lines, and Lloyd's retroactive markets. The company competes primarily against global reinsurers and Bermuda insurance groups—including Munich Re, Swiss Re, Everest, Arch, and RGA—on pricing power, capital deployment efficiency, and catastrophe modeling sophistication. Its financial performance hinges on catastrophe frequency and severity outcomes, the adequacy of reserves and underwriting decisions, access to capital and funding markets, and shifts in regulation or contract terms that reshape pricing dynamics and capital requirements.
RenaissanceRe operates as a global specialty reinsurer with emphasis on property catastrophe, specialty reinsurance and retrocession. Its peers include other large global reinsurers and Bermuda-based multi-line groups offering both treaty and facultative capacity alongside alternative capital providers. The business faces material exposure to catastrophe frequency and claim volatility, pricing and capacity cycle dynamics (notably competition from insurance-linked securities and large institutional capital), reserve and underwriting adequacy, and balance-sheet vulnerabilities where investment losses can compound underwriting pressure.
| Company | Ticker |
|---|---|
| Munich Reinsurance Company | MUV2.XETRA |
| Swiss Re Ltd. | SREN.SW |
| SCOR SE | SCR.PA |
| Everest Re Group, Ltd. | EG.NYSE |
| Arch Capital Group Ltd. | ACGL.NASDAQ |
| AXIS Capital Holdings Limited | AXS.NYSE |
| PartnerRe Ltd. (Coventry/PartnerRe operations) | PRE.NYSE |
| Berkshire Hathaway Reinsurance (Berkshire Hathaway Inc.) | BRK-B.NYSE |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free Trial| Period | Renaissancere Holdings Ltd | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +0.09% | -6.39% | -4.36% |
| 3M | +8.51% | -0.26% | +3.14% |
| 6M | +5.58% | -0.19% | -8.72% |
| 1Y | +36.14% | +27.60% | +14.15% |
| 3Y | +85.46% | +16.80% | +0.76% |
| 5Y | +105.62% | +39.56% | +18.55% |
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHow the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 5.1 | 1.3 | 1.1 | 3.7 |
| 1Y ago | 5.8 | 0.9 | 1.1 | 3.0 |
| 3Y ago | 20.4 | 1.1 | 1.1 | 4.3 |
| 5Y ago | 17.9 | 1.5 | 1.1 | 5.3 |
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 0.41 USD | — | 0.17% |
| 2026 | 0.41 USD | 0.14% | |
| 2026 | 0.41 USD | 0.14% | |
| 2025 | 0.40 USD | 0.15% | |
| 2025 | 0.40 USD | 0.16% | |
| 2025 | 0.40 USD | 0.16% | |
| 2025 | 0.40 USD | 0.17% | |
| 2024 | 0.39 USD | 0.15% | |
| 2024 | 0.39 USD | 0.15% | |
| 2024 | 0.39 USD | 0.18% | |
| 2024 | 0.39 USD | 0.16% | |
| 2023 | 0.38 USD | 0.19% | |
| 2023 | 0.38 USD | 0.19% | |
| 2023 | 0.38 USD | 0.20% | |
| 2023 | 0.38 USD | 0.20% |
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 12.75B | 11.65B | 9.09B | 5.05B | 5.27B |
| Operating income (EBIT) | 4.13B | 3.09B | 3.20B | -1.17B | -66.57M |
| Net income | 2.68B | 1.87B | 2.56B | -1.06B | -40.16M |
| Free cash flow | 3.69B | 4.16B | 1.91B | 1.12B | 1.23B |
| Total assets | 53.80B | 50.71B | 49.01B | 36.55B | 33.96B |
| Equity | 11.61B | 10.57B | 9.45B | 9.86B | 10.18B |
| Net debt | 598.02M | 210.09M | 81.14M | -23.90M | -690.67M |